Sign in
Taking peopleNo phase

Program to Improve High Blood Pressure Care in Africa

Tests a bundle of care programs to help adults with high blood pressure in Africa.

Key facts

Who runs it
Johns Hopkins University
Where
Baltimore, United StatesSee the siteAlso in 2 other countries, 16 sites
Trial code
Registry title
Addressing Hypertension Care in Africa Program
Status
Recruiting
People taking part
800 people, planned
Started
9 Jan 2026
Expected to end
Sept 2028
Type of study
Interventional, 4 groups
Treatments tested
  • ADHINCRA Program
Record updated
14 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 70 with high blood pressure who have not had treatment or take one blood pressure medicine. They must not have diabetes.

Age
18 to 70 years
Sex
All sexes can join.
Disease stage
A diagnosis of hypertension, with a top blood pressure number (systolic) of 140 mmHg or higher at the most recent clinic visit, and no diabetes diagnosis.
Earlier treatment
No treatment for hypertension so far, or treatment with one blood pressure medicine only (monotherapy).

Main reasons for not taking part

  • Severely high blood pressure (180/110 mmHg or higher)
  • Stroke, coronary artery disease or kidney disease
  • End-stage kidney disease treated with dialysis
  • Serious medical condition, such as cancer, that limits life expectancy or needs active management
  • Pregnant or currently nursing a child

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Aged 18 -70 years
  • Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis
  • Hypertension treatment naive or on monotherapy
  • Receives primary care at one of the participating sites
  • Willing and able to provide informed consent in English, Twi, Dagbani, Ewe, Hausa, or Yoruba
  • Owns a smartphone (Android or iOS)

Who cannot take part

  • Diagnosis of end-stage renal disease (ESRD) treated with dialysis
  • Diagnosis of stroke, coronary artery disease, or kidney disease
  • Serious medical condition which either limits life expectancy or requires active management (e.g., cancer)
  • Cognitive impairment or other conditions preventing study participation
  • Age <18 years or >70 years
  • Severely elevated BP (≥180/110mmHg)
  • Pregnant or currently nursing a child
  • Unwilling to provide informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

Also in 2 other countries, 16 sites

  • Johns Hopkins UniversityBaltimore, United StatesContact: Yvonne Commodore-Mensah, PhD, MHS, RNNo longer taking part

About the trial

What the trial wants to find out

The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.

The 4 groups in the trial

  • Cohort 1Treatment being tested

    This cohort will be the first to participate in the ADHINCRA Program, which includes home blood pressure monitoring, an mHealth app, nurse-led lifestyle counselling and treatment with a simplified hypertension control protocol.

    Treatment: ADHINCRA Program

  • Cohort 2Treatment being tested

    This cohort will begin the ADHINCRA Program 3 months after Cohort 1.

    Treatment: ADHINCRA Program

  • Cohort 3Treatment being tested

    This cohort will begin the ADHINCRA Program 6 months after Cohort 1.

    Treatment: ADHINCRA Program

  • Cohort 4Treatment being tested

    This cohort will begin the ADHINCRA Program 9 months after Cohort 1.

    Treatment: ADHINCRA Program

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Addressing Hypertension Care in Africa (ADHINCRA) Program
Plain-language title
Program to Improve High Blood Pressure Care in AfricaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06986590, who can take part
Record updated
14 January 2026